Search

Your search keyword '"Van Braeckel, Eva"' showing total 311 results

Search Constraints

Start Over You searched for: Author "Van Braeckel, Eva" Remove constraint Author: "Van Braeckel, Eva"
311 results on '"Van Braeckel, Eva"'

Search Results

2. Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study

3. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

5. Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC)

8. Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials

9. CPAnet Registry-An International Chronic Pulmonary Aspergillosis Registry.

10. Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome.

12. Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment

13. Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial

14. Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial

17. Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial

18. Baseline chest computed tomography for diagnosis of invasive aspergillosis in patients with acute myeloid leukaemia treated with intensive chemotherapy: A retrospective single‐centre cohort study

19. Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study

20. Aspergillus and the Lung

21. Baseline chest computed tomography for diagnosis of invasive aspergillosis in patients with acute myeloid leukaemia treated with intensive chemotherapy:A retrospective single-centre cohort study

22. Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)

24. Growing from common ground: nontuberculous mycobacteria and bronchiectasis.

28. Pooling isolates to address the diversity in antimicrobial susceptibility of Pseudomonas aeruginosa in cystic fibrosis

32. An international perspective on hospitalized patients with viral community-acquired pneumonia

33. Expansion of MALDI-TOF MS database as a strategy for identification of Haemophilusspecies other than H. influenzae

36. Addressing an unmet need in the management of nontuberculous mycobacterial infections in Belgium: 1 year experience of the NTM consilium

37. Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared to the reference standard

39. Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial

41. A complement atlas identifies interleukin-6–dependent alternative pathway dysregulation as a key druggable feature of COVID-19

45. Management Challenges of Extrapulmonary Nontuberculous Mycobacterial Infection: A Single-Center Case Series and Literature Review.

46. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study

48. EQUAL CPA Score 2022: a tool to measure guideline adherence for chronic pulmonary aspergillosis

49. Video-assisted thoracic surgery in critically ill COVID-19 patients on venovenous extracorporeal membrane oxygenation.

50. Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials

Catalog

Books, media, physical & digital resources